Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
65,694,131
-
Shares change
-
+6,979,206
-
Total reported value, excl. options
-
$725,976,226
-
Value change
-
+$84,236,126
-
Put/Call ratio
-
58%
-
Number of buys
-
105
-
Number of sells
-
109
-
Price
-
$11.05
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2025
As of 30 Sep 2025 Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) had 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 65,694,131 shares of stock of the company.
Largest 10 holders included TANG CAPITAL MANAGEMENT LLC, BlackRock, Inc., NEA Management Company, LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, STATE STREET CORP, MORGAN STANLEY, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 239 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.